Replies to post #226694 on Avid Bioservices Inc (CDMO)

[md1225]

Roy nice to have you here! Will appreciate your input as things quickly unfold over the coming weeks.

Bavituximab Yervoy melanoma combo data coming up. I'm told it's as good as Dr Hutchins was reporting in the winter in his preclinical symposium.

Now we have the first safe combo immunotherapy that actually is showing a doubling of efficacy in humans over Yervoy alone in melanoma.

Literally miraculous.